CAR T cell therapy for autoimmune disease gains traction Bristol Myers Squibb unveiled promising CAR T cell therapy data for severe autoimmune diseases from their Phase 1 clinical trial, offering hope for remission.

https://www.drugdiscoverynews.com/car-t-cell-therapy-for-autoimmune-disease-gains-traction-16173?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-8uPcdb1-hdINVPHE5Oz6SK3cinatdivu7EvysGh9Gg5TccI5G0yg987Erc1-S7fs-vmuqTVHBM8dHygb4FenJzK90qSw&_hsmi=339585239&utm_content=339585239&utm_source=hs_email